GDC0941
Showing 1 - 18 of 18
Advanced Solid Tumours, Breast Cancer Trial in London, Manchester (Palbociclib + Taselisib / Pictilisib)
Unknown status
- Advanced Solid Tumours
- Breast Cancer
- Palbociclib + Taselisib / Pictilisib
-
London, United Kingdom
- +1 more
Nov 15, 2019
Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM.D. Anderson Cancer Center
Apr 17, 2023
HER2-positive Breast Cancer, Metastatic Breast Cancer Trial in Seoul (Trastuzumab biosimilars(Herzuma), Gedatolisib)
Unknown status
- HER2-positive Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab biosimilars(Herzuma), Gedatolisib
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 16, 2021
Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast
Terminated
- Estrogen Receptor Negative Breast Cancer
- +5 more
- cisplatin
- +4 more
-
Birmingham, Alabama
- +15 more
May 22, 2017
Healthy Volunteers Trial in South San Francisco (GDC-0941, rabeprazole)
Completed
- Healthy Volunteers
-
South San Francisco, CaliforniaGenentech Trial Information Support
Feb 7, 2017
Non-Squamous NSCLC, Solid Cancers Trial in Netherlands, United States (GDC-0941, erlotinib HCl)
Completed
- Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers
- GDC-0941
- erlotinib HCl
-
Aurora, Colorado
- +3 more
Nov 1, 2016
Non-Hodgkin's Lymphoma, Solid Cancers Trial in Sutton (GDC-0941)
Completed
- Non-Hodgkin's Lymphoma, Solid Cancers
-
Sutton, United Kingdom(unnamed)
Nov 1, 2016
Non-Squamous NSCLC Trial in Buffalo, Villejuif, Groningen (GDC-0941, bevacizumab, carboplatin)
Completed
- Non-Squamous Non-Small Cell Lung Cancer
- GDC-0941
- +5 more
-
Buffalo, New York
- +2 more
Nov 1, 2016